Rob Lenz
Head of Research and DevelopmentatNeumora Therapeutics· In the 2023 proxy
Pay in FY2023
Rob Lenz was paid $13.6M in FY2023 (Dec).
PayNo stock prices for these years
Experience
- Neumora TherapeuticsPublic company · 3 yr
- Head of Research and Development2023 – Present · 3 yrStock in role -98%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?